Gregis G - Search Results

1

Strategic selective treatment in highly pre-treated HIV patients harbouring multiply resistant viruses.

Maggiolo F, Callegaro A, Gregis G, Quinzan G, Ripamonti D, Arici C, Goglio A, Suter F. Maggiolo F, et al. Among authors: gregis g. AIDS. 2002 Jan 25;16(2):298-9. doi: 10.1097/00002030-200201250-00024. AIDS. 2002. PMID: 11807319 No abstract available.

2

CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART.

Maggiolo F, Airoldi M, Callegaro A, Martinelli C, Dolara A, Bini T, Gregis G, Quinzan G, Ripamonti D, Ravasio V, Suter F. Maggiolo F, et al. Among authors: gregis g. AIDS. 2009 Apr 27;23(7):799-807. doi: 10.1097/QAD.0b013e328321b75e. AIDS. 2009. PMID: 19114869 Clinical Trial.

3

Outcome of 2 simplification strategies for the treatment of human immunodeficiency virus type 1 infection.

Maggiolo F, Ripamonti D, Ravasio L, Gregis G, Quinzan G, Callegaro A, Arici C, Suter F. Maggiolo F, et al. Among authors: gregis g. Clin Infect Dis. 2003 Jul 1;37(1):41-9. doi: 10.1086/375598. Epub 2003 Jun 23. Clin Infect Dis. 2003. PMID: 12830407 Clinical Trial.

4

Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Quinzan G, Arici C, Airoldi M, Suter F. Maggiolo F, et al. Among authors: gregis g. Clin Infect Dis. 2005 Jan 1;40(1):158-63. doi: 10.1086/426595. Epub 2004 Dec 6. Clin Infect Dis. 2005. PMID: 15614706

5

Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.

Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, Ravasio L, Suter F. Maggiolo F, et al. Among authors: gregis g. HIV Clin Trials. 2002 Sep-Oct;3(5):371-8. doi: 10.1310/98b3-pwg8-pmyw-w5bp. HIV Clin Trials. 2002. PMID: 12407486

6

Salvage therapy with abacavir in HIV-1-infected patients with previously documented M184V mutation: a possibility of NRTI recycling.

Maggiolo F, Callegaro A, Arici C, Quinzan G, Gregis G, Ripamonti D, Tebaldi A, Goglio A, Suter F. Maggiolo F, et al. Among authors: gregis g. Antivir Ther. 2003 Apr;8(2):121-6. Antivir Ther. 2003. PMID: 12741624 Clinical Trial.

7

Quadruple-drug induction HAART in advanced HIV infection.

Maggiolo F, Ripamonti D, Callegaro A, Gregis G, Quinzan G, Suter F. Maggiolo F, et al. Among authors: gregis g. HIV Clin Trials. 2005 Jan-Feb;6(1):1-4. doi: 10.1310/LBGE-NMMX-CE1A-AK0Y. HIV Clin Trials. 2005. PMID: 15765306 Clinical Trial.

8

Prediction of Virologic Outcome of Salvage Antiretroviral Treatment by Different Systems for Interpreting Genotypic HIV Drug Resistance.

Maggiolo F, Airoldi M, Callegaro A, Ripamonti D, Gregis G, Quinzan G, Bombana E, Ravasio V, Suter F. Maggiolo F, et al. Among authors: gregis g. J Int Assoc Physicians AIDS Care (Chic). 2007 Jun;6(2):87-93. doi: 10.1177/1545109707299632. J Int Assoc Physicians AIDS Care (Chic). 2007. PMID: 17537998

9

Reasons for discontinuation of nevirapine-containing HAART: results from an unselected population of a large clinical cohort.

Maggiolo F, Arici C, Airoldi M, Ripamonti D, Quinzan G, Gregis G, Ravasio V, Bombana E, Suter F. Maggiolo F, et al. Among authors: gregis g. J Antimicrob Chemother. 2007 Mar;59(3):569-72. doi: 10.1093/jac/dkl534. Epub 2007 Jan 25. J Antimicrob Chemother. 2007. PMID: 17255141

10

Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure.

Maggiolo F, Callegaro A, Cologni G, Bernardini C, Velenti D, Gregis G, Quinzan G, Soavi L, Iannotti N, Malfatto E, Leone S. Maggiolo F, et al. Among authors: gregis g. J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):473-82. doi: 10.1097/QAI.0b013e3182567a57. J Acquir Immune Defic Syndr. 2012. PMID: 22481602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters